Banded-RYGB outcomes show maintenance of weight loss out to ten yearsThe addition of a silicone ring to a Roux-en-Y gastric bypass (banded- RYGB) results in the maintenance of weight loss ten years...
AOMs result in 8% relative risk reduction in any CVD events in patients with obesityThe utilisation of anti-obesity medications (AOMs) among people with obesity could potentially alleviate the high prevalence of...
Journal Watch 15/05/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatmentTwo studies presented at this year's European Congress on Obesity in Venice, Italy, have reported that tirzepatide consistently reduces...
Gut bacteria that strongly influence obesity are different in men and womenChanges in the composition of gut bacteria that may play a key role in the onset and development of obesity, with differences in men and...
Size of adipose cells may indicate future weight gainResearchers from Karolinska University Hospital Huddinge, Stockholm, Sweden, have suggested that it is possible to predict if someone is...
Evidence of body dysmorphia in social media profiles of people living with obesityMany people who are living with obesity conceal their body in their WhatsApp profile pictures, according to the findings of a study...
Poor muscle health common in people living with obesity increases early mortality riskPoor muscle health is associated with a higher risk of an early death in people living with obesity and individuals with adverse muscle...
Sex differences in how adipose tissue responds to insulin could explain why T2D is more prevalent in malesFor Individuals who are living with obesity, adipose tissue insulin resistance is more severe in men than in women and may partly explain...
AOMs result in 8% relative risk reduction in any CVD events in patients with obesityThe utilisation of anti-obesity medications (AOMs) among people with obesity could potentially alleviate the high prevalence of...
Factors influencing pharmacokinetic changes following restrictive and metabolic bariatric surgeryPharmacokinetic (PK) changes following both restrictive and metabolic bariatric surgery are drug-specific and highly variable according...
Mazdutide superior compared with dulaglutide for glycaemic control, weight loss, blood lipid and pressureInnovent Biologics’ Phase 3 clinical trial (DREAMS-2) of mazdutide (IBI362) in Chinese subjects with type 2 diabetes (T2D) has met its...
Journal Watch 8/5/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Top 10 most read articles on Bariatric News in AprilIt was another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought you the...
FDA approves Wegovy for CVD risk reduction in people with overweight or obesity and established cardiovascular disease